Beijing Health (Holdings) Limited AI Stock Analysis
Want to see HK:2389 full AI Analyst Report?
Beijing Health (Holdings) Limited (2389) AI Stock Analysis
Beijing Health (Holdings) Limited
(HKEX:2389)
The score is primarily constrained by persistent losses and weak cash generation, with the conservative balance sheet providing only partial support. Technical conditions are mixed, while the negative P/E and absent dividend yield provide no valuation cushion.
Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 466.53M
- Dividend Yield
- ―
- Average Volume (3M)
- 436.53K
- Price to Earnings (P/E)
- -4.5
- Beta (1Y)
- 0.03
- Revenue Growth
- -27.63%
- EPS Growth
- -16.33%
- Country
- Hong Kong
- Employees
- 202
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Beijing Health (Holdings) Limited Business Overview & Revenue Model
Company Description
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial pa...
Beijing Health (Holdings) Limited Financial Statement Overview
Summary
Persistent annual losses, negative operating results, and consistently weak or negative free cash flow outweigh the company’s conservative balance sheet and recent revenue recovery.
Income Statement
22NegativeBalance Sheet
55NeutralCash Flow
18Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.89M | 157.20M | 149.94M | 140.35M | 166.48M | 203.78M |
| Gross Profit | 17.21M | 42.45M | 35.68M | 38.47M | 46.51M | 46.99M |
| EBITDA | -47.76M | -77.41M | -97.47M | -44.19M | -75.25M | -10.37M |
| Net Income | -103.47M | -100.91M | -116.22M | -61.88M | -97.70M | -39.41M |
Balance Sheet | ||||||
| Total Assets | 2.05B | 2.10B | 1.95B | 2.18B | 2.42B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 220.43M | 237.36M | 211.08M | 335.96M | 440.76M | 496.30M |
| Total Debt | 31.70M | 114.16M | 5.65M | 4.89M | 32.75M | 48.37M |
| Total Liabilities | 294.41M | 343.11M | 209.74M | 223.82M | 271.77M | 341.34M |
| Stockholders Equity | 1.67B | 1.66B | 1.72B | 1.89B | 2.04B | 2.29B |
Cash Flow | ||||||
| Free Cash Flow | -58.10M | -18.02M | -42.20M | -45.10M | -12.34M | 406.00K |
| Operating Cash Flow | -47.70M | -5.49M | -35.56M | -43.72M | -11.19M | 1.99M |
| Investing Cash Flow | 108.91M | 154.75M | -33.80M | 74.76M | 22.77M | -227.83M |
| Financing Cash Flow | -135.51M | -88.80M | -5.28M | -68.40M | -17.71M | -20.46M |
Beijing Health (Holdings) Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.07, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 68.57 is Neutral, neither overbought nor oversold. The STOCH value of 42.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2389.
Beijing Health (Holdings) Limited Peers Comparison
Overall Rating
HK:607866Neutral
HK:386954Neutral
HK:388648Neutral
HK:072242Neutral
HK:238942Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 66Neutral | HKD 6.57B | 31.38 | 2.55% | ― | 1.59% | -58.55% | |
| 54Neutral | HKD 442.22M | -136.05 | -0.41% | ― | 3.16% | -101.02% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | HKD 1.22B | 86.19 | 0.48% | 1.00% | -3.26% | ― | |
| 42Neutral | HKD 300.36M | -3.89 | -10.76% | 8.80% | -1.37% | -334.69% | |
| 42Neutral | HKD 466.53M | -4.53 | -6.22% | ― | -27.63% | -16.33% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2389 | Beijing Health (Holdings) Limited | 0.08 | 0.00 | 4.05% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.20 | -2.68 | -45.58% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.18 | -0.08 | -31.30% | |
| HK:6078 | Hygeia Healthcare Holdings Co., Ltd. | 10.70 | -2.30 | -17.69% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.38 | -0.07 | -15.35% |
Beijing Health (Holdings) Limited Corporate Events
Beijing Health Widens Interim Loss as Revenue Slumps but FX Gains Ease Overall Hit
Beijing Health (Holdings) Limited reported a sharp decline in revenue for the six months ended 30 June 2026, with sales falling to HK$30.3 million from HK$76.6 million a year earlier and gross profit dropping to HK$3.8 million. Higher selling and dis...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026
